UMIN-CTR History

Name:  UMIN ID:


Unique ID issued by UMIN UMIN000015168
Receipt number R000017287
Scientific Title Investigation of optimal regimen of Fulvestrant in patients with postmenopausal ER-positive advanced recurrent breast cancer
Date of disclosure of the study information 2014/09/16
Last modified on 2021/08/06 08:24:51

No. Disposal Last modified on Item of update
1 Insert 2014/09/16 09:43:56
2 Update 2014/09/25 16:26:45 UMIN ID1
3 Update 2015/01/14 16:05:02 Recruitment status
4 Update 2015/03/20 13:12:49 Institutions
5 Update 2015/04/16 11:25:11 Institutions
6 Update 2015/04/16 11:25:50 Recruitment status
7 Update 2015/09/16 17:39:15 Organization
Organization
Division name
Division name
Address
Address
8 Update 2016/07/08 15:31:55 Name of primary person or sponsor
Organization
9 Update 2016/09/28 09:29:55 Publication of results
10 Update 2018/08/23 15:16:47 Recruitment status
Last follow-up date
11 Update 2018/08/23 17:44:10 Public title
12 Update 2018/08/24 10:10:07 UMIN ID1
13 Update 2019/09/05 15:23:54 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Zip code
Address
Address

Last name of contact person

Last name of contact person
Zip code
Address
Address
Organization
Organization
Address
Address
Tel
Email
14 Update 2019/09/05 15:27:56 Number of participants that the trial has enrolled
15 Update 2019/09/05 15:35:54 Date of IRB
Last follow-up date
Date of closure to data entry
Date trial data considered complete
16 Update 2019/09/05 15:36:47 Results Delayed
Results Delay Reason
Results Delay Reason
17 Update 2021/03/08 11:11:28 Narrative objectives1
Narrative objectives1
Key secondary outcomes
Key secondary outcomes
18 Update 2021/03/08 11:42:16 1st name of lead principal investigator
Last name of lead principal investigator
1st name of lead principal investigator
Last name of lead principal investigator
Organization
Organization
Division name
Division name
Organization
Organization
Name of secondary funder(s)
Name of secondary funder(s)
19 Update 2021/06/16 15:31:41
Last name of contact person

Last name of contact person
Division name
Name of person sending information
Name of person sending information
Organization
Division name
Institute
20 Update 2021/06/21 17:54:41 Homepage URL
21 Update 2021/08/06 08:24:51 URL releasing protocol
Publication of results
URL related to results and publications
Number of participants that the trial has enrolled
Results
Results
Results date posted
Results Delayed
Results Delay Reason
Results Delay Reason
Date of the first journal publication of results
Baseline Characteristics
Baseline Characteristics
Participant flow
Participant flow
Adverse events
Adverse events
Outcome measures
Outcome measures